Alaway®
ketotifen 0.025% (as ketotifen fumarate 0.035%) · ophthalmic solution
Allergy
Same formulation, different label. Identical to Zaditor®. Choose on price and availability, not on the drug.
Approved uses
Itchy eyes due to ragweed, pollen, grass, animal hair and dander
Adults and children 3 years and older: 1 drop in the affected eye(s) BID, every 8 to 12 hours, no more than twice per day
Itch relief begins within 15 minutes of instillation and lasts at least 8 hours.
Contraindications
- Sensitivity to any ingredient in the product
- Contact lens related irritation
- Solution that changes color or becomes cloudy
Ophthalmic solution, ketotifen 0.25 mg/mL (as ketotifen fumarate 0.035%), 5 mL and 10 mL dropper bottles, 10 mL also in a twin pack
H1 receptor antagonist that also stabilizes mast cells and inhibits eosinophil chemotaxis and activation, blocking the itch mediator while limiting further mediator release. That dual action gives onset within 15 minutes and effect persisting at least 8 hours after a single drop.
Warnings & Precautions
- When using this product: Remove contact lenses before use, and wait at least 10 minutes before reinserting them after use.
- Do not use: If you are sensitive to any ingredient in this product, if the solution changes color or becomes cloudy, or to treat contact lens related irritation.
- Stop use and ask a doctor: Eye pain, changes in vision, redness of the eyes, or itching that worsens or lasts for more than 72 hours.
- Tip contamination: Do not touch the container tip to any surface, and replace the cap after each use.
- Keep out of reach of children: For external use only; if swallowed, get medical help or contact a Poison Control Center right away.
Common Side Effects
- Ocular: Instillation discomfort. In a masked contralateral-eye comparison, treated eyes were rated significantly less comfortable than olopatadine 0.1% immediately after instillation (mean 2.09 vs 1.25).
- Systemic: None drug-related in a randomized pediatric trial dosing BID for 4 weeks; ocular adverse event rates matched placebo and no subject discontinued for an adverse event.
Pregnancy: The label has no pregnancy section and does not address use in pregnancy.
Lactation: The label has no nursing mothers section and does not address use during breastfeeding.
Labeled for ages 3 and older; efficacy with placebo-level ocular tolerability shown in a randomized trial in 8 to 16 year olds.